Universal to all cell therapies (CT) is the need to determine the number of cells at each step of the manufacturing process as they are processed in different unit operations and developed into clinically relevant final CT products.
No takes yet. Share an insight, caveat, or question.
Saedeh et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: